Results 181 to 190 of about 276,470 (294)

Antiparasitic Effect of Artemisinin Drug on Alanine Transaminase, Aspartate Transaminase, Cholesterol and Triglyceride in Infected Mice with Leishmania donovani

The Iraqi Journal of Medical Sciences
Background: The pathogenic risk caused by the Leishmania donovani (L. donovani) parasite has long been known, and it has become necessary to find a suitable treatment other than traditional medications and their many side effects, among the best ...
Zahraa A. Ali, Hadeel A. Majeed
doaj   +2 more sources

Metabolic Factors Associated with Alanine Transaminase Levels in Non-Alcoholic Fatty Liver Disease

Proceedings
Background: Non-Alcoholic Fatty Liver Disease is the most increasing chronic liver condition with a global prevalence of 30%. Metabolic factors like Obesity, Diabetes Mellitus are considered as major risk factors.
Safwa Mahmood, Minahil Atique, Amir Rafeeq, Aaman Inaam Khan, Safwa Mahmood, Maham Akhlaq   +5 more
doaj  

Association of Beverage Consumption with Cardio-metabolic Risk Factors and Alanine Transaminase Levels in Children and Adolescents: The CASPIAN-V Study. [PDF]

Adv Biomed Res
Khademian M, Shahsavari A, Qorbani M, Motlagh ME, Heshmat R, Khozani ES, Najafi MA, Mansourian M, Kelishadi R.   +8 more
europepmc   +1 more source

[Discussion regarding the reduction of the alanine transaminase threshold value in patients with chronic hepatitis B virus infection undergoing antiviral therapy]. [PDF]

Zhonghua Gan Zang Bing Za Zhi, 2023
Du YN, Cai W.
europepmc   +1 more source

Overcoming Drug Resistance by Paclitaxel Resistance in Triple‐Negative Breast Cancer

Advanced Science, EarlyView.
In the murine triple‐negative breast cancer (TNBC) model, chemotherapy effectively increases tumor neoantigen burden (TNB). Here, the study constructs a liposomal nanovaccine using antigens derived from in vitro chemotherapy‐treated paclitaxel‐resistant TNBC 4T1 cells.
Bo Chen, Yangyi Wang, Tingting Li, Changqing Guo, Zhe Xie, Zhixian Zhang, Xinghua Han, Wei Wang, Jian Wang, Xiaopeng Ma, Yuanzeng Min   +10 more
wiley   +1 more source

Elevated Alanine Transaminase-to-Platelet Index (APRI) Is Associated with Obesity and Distinct Forms of Dyslipidemia: A Retrospective Cross-Sectional Study. [PDF]

J Clin Med
Alshuweishi Y, Alfayez D, Almufarrih AA, Abudawood A, Alyami H, Alshuweishi FA, Al-Sheikh YA, Alfhili MA.   +7 more
europepmc   +1 more source

A Cascaded DNA Nanocircuit for Multi‐Signal‐Responsive Precision siRNA Delivery in Cancer Therapy

Advanced Science, EarlyView.
A cascaded dual‐AND logic DNA nanocircuit is engineered to respond to three tumor‐specific signals in a sequential manner: extracellular acidic pH, membrane‐overexpressed nucleolin (NCL), and intracellular glutathione (GSH). This programmable system selectively releases siPARP1 in glioblastoma (GBM), effectively silencing PARP1 and reversing TMZ ...
Yan Zhao, Yufei Lan, Min‐Goo Lee, Jinjun He, Yueran Pan, Eunji Kim, Xin Fu, Sungwook Jung, Wanxia Lu, Jinyue Fan, Haoxiang Chen, Yuanbo Zhao, Yuling Xu, Jong Seung Kim, Chao Zhang   +14 more
wiley   +1 more source

Lower HBV DNA level is associated with more severe liver fibrosis in HBeAg-positive chronic hepatitis B with normal alanine transaminase. [PDF]

Virol J
Wang J, Zhu L, Zhang Z, Zhang S, Pan Y, Li Y, Cao F, Jiang C, Fan T, Xiong Y, Liu J, Chen Y, Yin S, Tong X, Zhu C, Liu X, Li J, Wu C, Huang R.   +18 more
europepmc   +1 more source

[Hepatic pathological characteristics and factors influencing alanine transaminase value below twice the upper limit of normal in patients with chronic hepatitis B]. [PDF]

Zhonghua Gan Zang Bing Za Zhi, 2023
Wang XH, Liu XQ, Cai DC, Hu P, Li H.
europepmc   +1 more source

Targeting the PHB2–ACSL3 Lipid‐Remodeling Axis Overcomes Cisplatin Resistance by Restoring Ferroptosis in Gastric Cancer

Advanced Science, EarlyView.
ABSTRACT Platinum‐based chemotherapy resistance remains a major obstacle in gastric cancer (GC) treatment. Through integrated transcriptomic profiling of cisplatin‐resistant xenografts and pharmacogenomic interrogation of the NCI‐60 dataset, we identified Prohibitin‐2 (PHB2) as a previously unrecognized determinant of chemoresistance.
Liang Xu, Wanying Xiang, Xinyue Wang, Yue Pan, Jing Gao, Jiezhen Yang, Yufei Wang, Zhipu Zhu, Man Tong, Lei Jin, Yan Ye   +10 more
wiley   +1 more source